Literature DB >> 11401674

Expression of the human erythrocyte glucose transporter Glut-1 in areas of sclerotic collagen in necrobiosis lipoidica.

C Holland1, V Givens, B R Smoller.   

Abstract

BACKGROUND: Glut-1 is the human erythrocyte glucose transporter which mediates facilitative transport of glucose across epithelial and endothelial barrier tissues. A primary abnormality in glucose transport and Glut-1 cell-surface content has been observed in fibroblasts from NIDDM and obese individuals. With the strong correlation between necrobiosis lipoidica and diabetes mellitus, we investigated the expression of Glut-1 in diabetic individuals with necrobiosis lipoidica (NL).
METHODS: A polyclonal anti-Glut-1 antibody was used with a standard immunoperoxidase technique to determine Glut-1 expression by fibroblasts in areas of sclerotic collagen from specimens taken from diabetic individuals with necrobiosis lipoidica,and non-diabetic individuals with scars and granuloma annulare (GA).
RESULTS: Our results showed Glut-1 expression in the areas of sclerotic collagen in patients with NL, possibly contributing to insulin resistance in these tissues.
CONCLUSIONS: Our findings raises the question as to whether abnormalities in glucose transport by fibroblasts in individuals with necrobiosis lipoidica contribute to the histopathologic changes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401674     DOI: 10.1034/j.1600-0560.2001.028006287.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

Review 1.  Cutaneous Granulomatosis: a Comprehensive Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Carlo Mainetti; Marie-Astrid Peeters; Emmanuel Laffitte
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Necrobiosis lipoidica diabeticorum: A case-based review of literature.

Authors:  Sunil Kumar Kota; Sruti Jammula; Siva Krishna Kota; Lalit Kumar Meher; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2012-07

3.  Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with oral thalidomide.

Authors:  Swapnil D Shah; Girish V Kale
Journal:  Indian Dermatol Online J       Date:  2016 Jan-Feb

4.  The role of anti-tumour necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and review of the literature.

Authors:  Vijay Kumari Sandhu; Afsaneh Alavi
Journal:  SAGE Open Med Case Rep       Date:  2019-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.